Skip to content
Application 211280
- Type
- NDA
- Sponsor
- ELI LILLY AND CO
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | REYVOW | LASMIDITAN SUCCINATE | TABLET;ORAL | 50MG | Yes | No |
| 002 | REYVOW | LASMIDITAN SUCCINATE | TABLET;ORAL | 100MG | Yes | Yes |
| 003 | REYVOW | LASMIDITAN SUCCINATE | TABLET;ORAL | 200MG | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4312 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4491 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4736 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4736 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4736 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |
| 0002-4736 | Reyvow | lasmiditan | Eli Lilly and Company | NDA | Current |